John D. Mendlein,Francine S. Farouz,R. Scott Thies,Daniel Shoemaker
申请号：
US13257291
公开号：
US20120207744A1
申请日:
2010.03.19
申请国别(地区):
US
年份:
2012
代理人:
摘要：
The present invention provides compositions and methods of using the compositions to alter the developmental potency of a cell. The present invention provides in vivo and ex vivo cell reprogramming and programming methods suitable for autologous cell therapy and regenerative medicine.
